Irreversible Electroporation Ablators Market Size, Share, Growth, And Industry Analysis, By Type (Generator, Part and Service), By Application (Liver, Pancreas, Prostate and Others), Regional Insights and Forecast From 2025 To 2033
Trending Insights

Global Leaders in Strategy and Innovation Rely on Our Expertise to Seize Growth Opportunities

Our Research is the Cornerstone of 1000 Firms to Stay in the Lead

1000 Top Companies Partner with Us to Explore Fresh Revenue Channels
Request a Free sample to learn more about this report
IRREVERSIBLE ELECTROPORATION ABLATORS MARKET REPORT OVERVIEW
The global irreversible electroporation ablators market size was USD 0.04 billion in 2024 and market is projected to touch USD 0.09 billion by 2033, exhibiting a CAGR of 9.1% during the forecast period from 2025 To 2033.
Ablators for irreversible electroporation (IRE) are medical devices used in a minimally invasive process to kill certain cells or tissues. Electrodes that resemble needles are used in the ablation system, and imaging methods are used to place them. After that, the electrodes are subjected to high-voltage electrical pulses that generate an electric field that permanently damages cell membranes. When compared to other ablative methods, irreversible electroporation ablators have benefits including less harm to the surrounding tissues and perhaps quicker recovery durations.
There are various reasons why the market for irreversible electroporation ablators is expanding. First, IRE attracts patients and medical professionals looking for safer and more efficient alternatives to conventional cancer therapies. Second, it is extremely desirable since it can target tumour cells specifically while causing the least amount of harm to nearby healthy tissues. In addition, IRE is becoming more widely used as a result of technological developments and an increase in clinical evidence supporting its effectiveness. The market for ablators has grown as a result of these forces working together.
COVID-19 IMPACT
Frequent Lockdowns to Hamper the Market Growth
The global COVID-19 pandemic has been unprecedented and staggering, with the irreversible electroporation ablators market experiencing lower-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden rise in CAGR is attributable to the market's growth and demand returning to pre-pandemic levels once the pandemic is over.
With resources being diverted to managing COVID-19 cases, the pandemic had disrupted healthcare systems across the globe. The need for the ablators temporarily decreased as a result of non-urgent medical operations, such as some cancer treatments, being cancelled or postponed. Additionally, the pandemic-related delays in supply chains and clinical trials had a negative impact on research and development efforts in the medical device sector. This delayed the market entry of new and improved IRE.
LATEST TRENDS
Development of Imaging Technology to Improve the Accuracy and Efficiency of IRE Ablation
The development of cutting-edge imaging techniques for process guidance is one of the newest trends in the irreversible electroporation ablators industry. With regard to precisely placing the electrodes and keeping track of treatment success, real-time imaging is essential. Imaging technology advancements, such as the incorporation of ultrasound, CT scan, or MRI guidance, can improve the accuracy and efficiency of IRE ablation.
IRREVERSIBLE ELECTROPORATION ABLATORS MARKET SEGMENTATION
By Type
According to type, the market can be segmented into generator, part and service.
By Application
Based on application, the market can be divided into liver, pancreas, prostate and others.
DRIVING FACTORS
Growing Demand for Minimally Invasive Procedures is Driving IRE Market
One major driving factor of the irreversible electroporation ablators market growth is the growing demand for minimally invasive procedures. Compared to traditional cancer treatments such as surgery, IRE ablation offers a less invasive approach that can be performed with smaller incisions, resulting in reduced trauma to the patient. This aspect is highly attractive to both patients and healthcare providers as it can lead to several benefits, including shorter hospital stays, faster recovery times, reduced pain, and lower risk of complications. The desire for minimally invasive procedures has increased as patients seek treatments that can improve their quality of life and reduce the impact of invasive interventions.
Capability of IRE to Selectively Target and Eliminate Particular Cells is Growing its Demand
Another important motivating force is the capability of IRE ablation to selectively target and eliminate particular cells or regions. IRE ablation uses high-voltage electrical pulses to permanently harm cell membranes, unlike certain other ablative methods that rely on heat or extreme cold. This method minimizes damage to neighboring healthy tissues while enabling precision targeting of tumor cells. Due to its capacity to selectively destroy tissue, irreversible electroporation ablators are especially useful for treating tumors that are close to functionally important systems including blood arteries, nerves, or bile ducts. This focused strategy improves treatment results and lowers the danger of problems brought on by harming surrounding healthy tissues.
RESTRAINING FACTORS
Requirement for Specialized Training is Limiting the Growth of the Ablators Market
The requirement for specialized training and experience in performing the operation is one issue limiting the growth of the irreversible electroporation ablators sector. A skilled healthcare practitioner is needed for IRE ablation who is capable of precisely placing the electrodes and choosing the right treatment parameters. The procedure's complexity might prevent it from being widely used as it calls for a degree of competence that might not be present in all healthcare settings. In some areas or medical institutions, the growth and accessibility of IRE ablation may be constrained by the requirement for specialized training and experience.
Request a Free sample to learn more about this report
IRREVERSIBLE ELECTROPORATION ABLATORS MARKET REGIONAL INSIGHTS
Well-established Healthcare Infrastructure is Aiding North America to Dominate the IRE Market
North America is expected to dominate the irreversible electroporation ablators market share for several reasons. Firstly, the region benefits from a well-established healthcare infrastructure, including advanced medical facilities and imaging technologies, facilitating the adoption and utilization of advanced procedures such as IRE ablation. Secondly, North America has a strong focus on research and development, with a robust ecosystem of research institutions and medical device companies driving innovation in the field. Furthermore, the presence of key market players and their extensive marketing efforts in the region have contributed to the widespread awareness and adoption of ablation. Lastly, favorable reimbursement policies and a high healthcare expenditure in North America have further facilitated market dominance.
KEY INDUSTRY PLAYERS
Key Players Focus on R&D to Enhance the Effectiveness and Safety of their Systems
To dominate the irreversible electroporation sector, players are focusing on several strategies. They are investing in research and development to enhance the effectiveness and safety of their IRE ablation systems. Market players are also actively collaborating with healthcare providers to conduct clinical studies, gather evidence, and expand the application of ablation in different tumor types. Furthermore, they are engaging in extensive marketing efforts to create awareness among healthcare professionals and patients about the benefits of ablation, and they are establishing strong distribution networks to ensure widespread availability of their products.
List of Top Irreversible Electroporation Ablators Companies
- AngioDynamics (U.S.)
- Pulse Biosciences (U.S.)
REPORT COVERAGE
This report covers the irreversible electroporation ablators market. The CAGR expected to be in during the forecast period, and also the USD value in 2025 and what it is expected to be in forecast period. The effect COVID-19 had on the market in the beginning of the pandemic. The latest trends taking place in this industry. The factors that are driving this market as well as the factors that are restraining the growth of industry. The segmentation of this market based on type and applications. The region leading in the industry and why they will continue to do so during the forecast period. Further, the key market players, what all is being done by them to stay ahead of their competition as well as retain their market positions. All these details are covered in the report.
Attributes | Details |
---|---|
Market Size Value In |
US$ 0.04 Billion in 2024 |
Market Size Value By |
US$ 0.09 Billion by 2033 |
Growth Rate |
CAGR of 9.1% from 2024 to 2033 |
Forecast Period |
2025-2033 |
Base Year |
2024 |
Historical Data Available |
Yes |
Regional Scope |
Global |
Segments Covered | |
By Type
|
|
By Application
|
FAQs
Based on our research, the global irreversible electroporation ablators market is projected to touch USD 0.09 billion by 2033.
The irreversible electroporation ablators market is expected to exhibit a CAGR of 9.1% over 2033.
The driving factors of the market are growing demand for minimally invasive procedures and capability of IRE to selectively target and eliminate cells.
The top companies operating in the market are AngioDynamics and Pulse Biosciences.